Ardelyx reported $75.92M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Amgen USD 1.94B 237M Dec/2025
Ardelyx USD 75.92M 7.69M Dec/2025
aTyr Pharma USD 82.26M 77.46M Dec/2025
Corcept Therapeutics USD 114.74M 7.77M Dec/2025
Curis USD 1.34M 3.45M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
TG Therapeutics USD 50.73M 12.64M Dec/2025
United Therapeutics USD 190.6M 38.6M Dec/2025
Xoma USD 11M 2.54M Jun/2024